key: cord-0795555-xlsa9tp9
authors: Fu, Lanyi; Yao, Maolin; Liu, Xuedong; Zheng, Dong
title: Using bioinformatics and systems biology to discover common pathogenetic processes between sarcoidosis and COVID-19
date: 2022-03-18
journal: Gene Rep
DOI: 10.1016/j.genrep.2022.101597
sha: 92841e83e3c834e47df4e92fb85964ed3876c46b
doc_id: 795555
cord_uid: xlsa9tp9

Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 is still raging worldwide. Patients with sarcoidosis have been experiencing increased severity of COVID-19; however, the underlying pathological mechanisms remain elusive. To determine common transcriptional signatures and pathways between sarcoidosis and COVID-19, we investigated the whole-genome transcriptome of peripheral blood mononuclear cells (PBMCs) from patients with COVID-19 and sarcoidosis, followed by various bioinformatic analyses, including gene ontology and pathways enrichment, protein-protein interaction (PPI) network and gene regulatory network (GRN) construction. We identified 33 abnormally expressed genes that were common between COVID-19 and sarcoidosis. Functional enrichment analysis showed that these differentially expressed genes were associated with cytokine production involved in immune response and T cell cytokine production. We identified several hub genes from the PPI network encoded by the common genes, which have high diagnostic potential for COVID-19 and sarcoidosis and could serve as promising biomarkers. Moreover, GRN analysis screened significant microRNAs and transcription factors that regulate the common genes. Thus, this study provides the first characterization of the transcriptional signatures and biological processes commonly dysregulated in sarcoidosis and COVID-19, and further identified several critical regulators and biomarkers. This study highlights a potential pathological association between COVID-19 and sarcoidosis, which can provide a theoretical basis supporting future clinical trials.

On March 11, 2020, the World Health Organization declared the novel coronavirus disease-2019 (subsequently named COVID-19) as a pandemic, which is caused by SARS-CoV-2, a positive-stranded RNA virus (Gorbalenya et al., 2020) . Recent reports have demonstrated that patients with pre-existing health conditions (e.g., cancer, heart disease, diabetes) have a higher risk of SARS-CoV-2 infection compared with the general population (Al-Quteimat and Amer, 2020; Peric and Stulnig, 2020; Radke et al., 2020) . Fortunately, researchers worldwide are striving to unravel therapeutic strategies that are effective for this population (A. M. A. Nashiry et al., 2021; Satu et al., 2021; Taz et al., 2021) . Sarcoidosis is a risk factor for COVID-19 . However, studies examining the pathological mechanisms that might help patients with sarcoidosis combat COVID-19 are lacking. samples, including 17 samples from healthy controls and 17 samples from patients with COVID-19. Among them, two patients were sampled twice in succession; thus, these repeated-measurement samples were excluded before analysis. RNA sequences of this dataset were obtained using the Illumina NextSeq 500 platform (Blanco-Melo et al., 2020) . The GSE42832 dataset contains the transcriptional profiles of PBMCs from healthy controls and patients with sarcoidosis. 10 samples, including five from healthy controls and five from patients with sarcoidosis, were extracted from this dataset to identify DEGs (Bloom et al., 2013) .

The R package "limma" was used (with default parameters) to identify DEGs associated with COVID-19 and sarcoidosis from the GSE164805 and GSE42832 datasets, respectively. The limma package uses linear models and moderated t-statistics to analyze microarray data; it provides normalization functions, supporting features that are especially useful for a linear modeling approach (Smyth, 2005) . We screened DEGs between controls and COVID-19 patients in the GSE152418 dataset using the R package "DESeq2," which uses shrinkage estimation for dispersions and fold changes to improve estimate stability and interpretability (Love et al., 2014) . For three datasets, a log2-fold change (absolute) > 1.0 and adjusted P-value < 0.05 were used as the cut-off criteria to identify DEGs. The Benjamini-Hochberg procedure was used to control the false discovery rate. The common DEGs among the GSE164805, J o u r n a l P r e -p r o o f GSE152418, and GSE42832 datasets were identified and visualized using the R packages.

We performed Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis to investigate the biological functions of the identified DEGs. GO analysis contains three aspects: cellular component (CC), molecular functions (MF), and biological process (BP) (Doms and Schroeder, 2005) . First, we used the R package "org.Hs.eg.db" to convert the IDs of overlapping DEGs.

Subsequently, we used the R packages "clusterprofiler" (Yu et al., 2012) and "GOplot" (Walter et al., 2015) for the GO and KEGG analysis. The species was limited to Homo sapiens. GO terms and pathways were declared to be significantly enriched when the adjusted P-value was < 0.05.

PPI networks help to untangle complex molecular mechanisms. PPI networks of sarcoidosis-specific genes, COVID-19-specific genes, and common genes between sarcoidosis and COVID-19 were respectively constructed using the Search Tool for Retrieval of Interacting Genes/Proteins (STRING: https://string-db.org/) database (Szklarczyk et al., 2019) . All DEGs were input into the STRING database as seed genes, and their neighboring interacting partners were also included in the network.

The generated PPI networks were exported to Cytoscape software (Shannon et al., 2003) and the hub genes in three networks were identified by the cytoHubba plugin J o u r n a l P r e -p r o o f (Chin et al., 2014) . We selected genes in the top 10 based on maximal clique centrality as hub genes. The diagnostic potential of hub genes in COVID-19 or sarcoidosis was tested using receiver operating characteristic (ROC) curve analysis.

An area under the ROC curve (AUC) of > 0.5 was considered statistically significant.

GRNs describe regulatory relationships between transcription factors (TFs) and microRNAs (miRNAs) and their target genes . We built DEG-TF and DEG-miRNA interaction networks using the JASPAR (Khan et al., 2018) and

Tarbase (Sethupathy et al., 2006) databases in the Network Analyst website (Zhou et al., 2019) to explore the effects of TFs and miRNAs on DEGs. The list of the generated DEG-TF and DEG-miRNA pairs was reintroduced into Cytoscape software for further visualization. Significant hub miRNAs and TFs were detected using the cytoHubba plugin in Cytoscape and ranked by the MCC value.

DEGs identified in COVID-19 and sarcoidosis from the three GEO datasets are presented as volcano plots in Fig. 1A -C, with 13,567, 2,157 and 773 DEGs identified in the GSE164805, GSE152418, and GSE42832 datasets, respectively; 33 DEGs were common to the three datasets, indicating a potentially common molecular mechanism contributing to COVID-19 and sarcoidosis pathology ( Fig. 1D -E, Table 1 ). The interactions among the 33 common DEGs based on the STRING database are shown in Fig. 1F . The heatmap in Fig. 1G shows that most of the DEGs were upregulated in the disease group compared with the corresponding expression in the normal controls.

COVID-19-specific DEGs were most strongly associated with the GO terms and KEGG pathways "regulation of mitotic nuclear division," "neuronal cell body," "extracellular matrix structural constituent conferring tensile strength," and "inflammatory mediator regulation of TRP channels" ( Fig. 2A) , whereas the sarcoidosis-specific DEGs were associated with "neutrophil mediated immunity," "tertiary granule," "pattern recognition receptor activity," and "phagosome" (Fig. 2B ).

The 33 common DEGs between sarcoidosis and COVID-19, were mainly enriched in the BP term "neutrophil degranulation", the CC term "tertiary granule lumen," the MF term "lgG binding", and the "amoebiasis" and "antifolate resistance" KEGG pathways (Fig. 2C ). Table 2 summarizes the top six GO items and KEGG pathways enriched by the common dysregulated genes in the two diseases.

The PPI network of sarcoidosis-specific DEGs contained 110 nodes and 146 edges Fig. 4 , indicating diagnostic potential of MCM3, MCM5, CDC27, CDC16, FABP5, ENO2, TAGLN, and ATF3 for COVID-19, and diagnostic potential of ACTR2, ACTR3, ARPC1B, ARPC1A, FABP5, ENO2, TAGLN, and ATF3 for sarcoidosis. These results revealed that hub genes identified from the PPI network of common DEGs had higher diagnostic potential in both COVID-19 and sarcoidosis than hub genes identified from the PPI network of disease-specific DEGs.

TFs and miRNAs regulate various biological processes, including pathological processes in sarcoidosis and COVID-19. We constructed miRNA-DEG and TF-DEG regulatory networks and identified several hub regulatory factors for each network.

For the 33 common DEGs, the TF-DEG network contained 36 nodes and 123 edges and the miRNA-DEG network contained 33 nodes and 98 edges (Fig. 5A) . For COVID-19-specific DEGs, the TF-DEG network contained 24 nodes and 54 edges and the miRNA-DEG network contained 44 nodes and 299 edges (Fig. 5B) . For sarcoidosis-specific DEGs, the TF-DEG network contained 46 nodes and 198 edges and the miRNA-DEG network contained 40 nodes and 244 edges (Fig. 5C ).

In December 2019, SARS-CoV-2 caused an outbreak of COVID-19; over 2 years later, the pandemic is still raging with significant global implications. Sarcoidosis is a J o u r n a l P r e -p r o o f risk factor for COVID-19; however, studies examining the pathological mechanisms that can help patients with sarcoidosis combat COVID-19 are lacking. Although a previous study reported the cellular pathways involved in sarcoidosis and COVID-19, only autophagy-related pathways were considered (Calender et al., 2020) . With a broader systems biology approach, our study identified pivotal genes, pathways, regulators, and biomarkers which were associated with COVID-19 and sarcoidosis, individually and together. These findings therefore offer novel potential therapeutic targets for patients with sarcoidosis and COVID-19. Moreover, to the best of our knowledge, our study is the first to collectively analyze the host transcriptional response to COVID-19 and sarcoidosis.

We performed differential expression analysis to identify the common DEGs between sarcoidosis and COVID-19 followed by enrichment analysis to reveal the potential common mechanisms. We identified 33 common DEGs, which were largely associated with cytokine-related signaling pathways. This finding implies that cytokines have a strong biological relevance with the pathogenesis of COVID-19 and sarcoidosis. Consistent with our findings, the research found that patients with COVID-19 present high cytokine signatures, which is considered to be the driving feature of COVID-19 (Blanco-Melo et al., 2020) . Similarly, multiple studies have reported exuberant inflammatory cytokine production in patients with sarcoidosis (Beirne et al., 2009; Gerke and Hunninghake, 2008) . Cytokines are soluble proteins that are often responsible for many infection-related symptoms, such as myalgia, J o u r n a l P r e -p r o o f fever, and headache (Slifka and Whitton, 2000) , which are also similar to COVID-19 symptoms.

PPI networks are fundamental in systems biology and help to detect critical molecules among proteins (Ewing et al., 2007) . We identified 10 hub proteins in the PPI network of common DEGs. ROC analysis showed that most of the hub proteins have high diagnostic potential (AUC > 0.7), suggesting their potential as biomarkers of COVID-19 and sarcoidosis. Among the hub genes, FKBP prolyl isomerase 1B (FKBP1B) is a member of the immunophilin family. Increased FKBP1b levels were reported to reverse calcium dysregulation and memory impairment in aging rats (Gant et al., 2015) . Activating transcription factor 3 (ATF3) is associated with various steps of tumorigenesis, and its decreased expression contributes to gastric cancer progression via increasing β-catenin and CEMIP levels (Xie et al., 2021) . Fatty acid binding protein 5 (FABP5) encodes a fatty acid binding protein, which has been shown to promote lymph node metastasis in cervical cancer (Zhang et al., 2020) .

Transgelin 3 (TAGLN3) contributes to the sequential progression of vertebrate neurogenesis (Ratié et al., 2014) . Enolase 3 (ENO3) is a metalloenzyme that acts as a tumor inhibitor in hepatocellular carcinoma development (Cui et al., 2021) . DNA damage inducible transcript 3 (DDIT3) is associated with many mineralization processes and inflammatory diseases, and suppresses cementoblast differentiation via the NF-κB pathway (Liu et al., 2019) . Enolase 2 (NEO2) encodes enolase isoenzymes that promote cell proliferation and glycolysis in acute lymphoblastic leukemia (Liu et (Liu et al., 2018) . Transgelin (TAGLN) encodes an actin cross-linking/gelling protein that mediates ovarian cancer progression via the RhoA/ROCK pathway (Wei et al., 2021) . Histidine triad nucleotide binding protein 1 (HINT1) mediates activation of MITF transcriptional activity in human melanoma cells (Motzik et al., 2017) .

GRNs are an essential component of bioinformatics, which describe the regulatory relationships between the TFs and miRNAs and their target genes. In this study, GRN analysis revealed that 36 TFs and 33 miRNAs could regulate the common DEGs.

Among those, hsa-mir-16-5p and FOXC1 showed the strongest interactions with the common DEGs. A previous study demonstrated that hsa-mir-16-5p can regulate ACE2-related networks (Wicik et al., 2020) . ACE2 is one of the main cellular receptors for SARS-CoV-2; the virus binds to ACE2 receptor to infiltrate host cells by binding the receptor and then rapidly replicate and spread, ultimately causing organ damage (Renhong et al., 2020) . Thus, this study suggests that hsa-mir-16-5p affects the clinical outcomes of patients with COVID-19. Forkhead box C1 (FOXC1) mediates chemotherapeutic resistance and the metastasis of gastric adenocarcinoma via the epithelial-to-mesenchymal transition and the Hedgehog pathway (Jun et al., 2021) .

This study has some limitations. We conducted an in-depth analysis of the transcriptomic data of COVID-19 and sarcoidosis to identify pivotal DEGs, pathways, regulators, and biomarkers. However, our findings have not been validated in vitro, ex vivo, and in vivo, and we hope to work on this in the future. Furthermore, we did not perform transcriptomic analyses in patients with sarcoidosis having COVID-19 owing to the current lack of relevant sample data. However, with continuous accumulation of samples in the future, this analysis is likely to become possible.

In the present study, we attempted to reveal the common pathological mechanisms between COVID-19 and sarcoidosis using multiple analytical approaches. We identified 33 common DEGs between COVID-19 and sarcoidosis. A total of 36 TFs and 33 miRNAs regulated the common DEGs, including hsa-mir-16-5p and FOXC1.

We also detected several hub proteins related to the common DEGs identified. The identified hub genes can serve as candidates for the diagnosis of patients with sarcoidosis having COVID-19. We believe our findings can provide a pathophysiological basis of patients with sarcoidosis having COVID-19, which can inform treatment to improve outcomes in this high-risk population. The first and fifth columns represent the gene symbol of the common genes between sarcoidosis and COVID-19 datasets; the second and sixth columns represent the log fold change between the groups; the third and seventh columns represent the t-statistics p-value; the fourth and eighth columns represent the adjusted p-values (p.adjust), which means p-value has been adjusted using Benjamini and Hochberg. The first and second columns show the gene symbol and full name of hub proteins. The third and fourth columns

Sarcoidosis presenting with glazy mucoid sputum and dyspnea: a case report

The impact of the COVID-19 pandemic on cancer patients

Sarcoidosis: a review for the internist

NCBI GEO: archive for functional genomics data sets--Update

Multiplex immune serum biomarker profiling in sarcoidosis and systemic sclerosis

Imbalanced host response to SARS-CoV-2 drives development of COVID-19

Transcriptional blood signatures distinguish pulmonary tuberculosis, pulmonary sarcoidosis, pneumonias and lung cancers

Modeling potential autophagy pathways in COVID-19 and sarcoidosis

CytoHubba: identifying hub objects and sub-networks from complex interactome

ENO3 inhibits growth and metastasis of hepatocellular carcinoma via Wnt/β-Catenin signaling pathway

GoPubMed: exploring pubmed with the gene ontology

Large-scale mapping of human protein-protein interactions by mass spectrometry

Reversal of aging-related neuronal Ca2+ dysregulation and cognitive impairment by delivery of a transgene encoding FK506-binding protein 12.6/1b to the hippocampus

The immunology of sarcoidosis

The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2

FOXC1 modulates stem-like cell properties and chemoresistance through Hedgehog and EMT signaling in gastric adenocarcinoma

JASPAR 2018: Update of the open-access database of transcription factor binding profiles and its web framework

Treatment of COVID-19 in patients with sarcoidosis. Front. Med. 8, 689539

Pulmonary sarcoidosis: from clinical features to pathology-narrative review

ENO2 promotes cell proliferation, glycolysis, and glucocorticoid-resistance in acute lymphoblastic leukemia

DDIT3 regulates cementoblast mineralization by isocitrate dehydrogenase 1 through nuclear factor-κB pathway

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

COVID-19 and sarcoidosis, readiness for vaccination: challenges and opportunities

Post-translational modification of HINT1 mediates activation of MITF transcriptional activity in human melanoma cells

Bioinformatics and system biology approach to identify the influences of COVID-19 on cardiovascular and hypertensive comorbidities

Bioinformatics and system biology approaches to identify the diseasome and comorbidities complexities of SARS-CoV-2 infection with the digestive tract disorders

Diabetes and COVID-19: disease-management-people

Adult congenital heart disease and the COVID-19 pandemic

Dynamic expression of notch-dependent neurogenic markers in the chick embryonic nervous system

Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2

Diseasome and comorbidities complexities of SARS-CoV-2 infection with common malignant diseases

TarBase: a comprehensive database of experimentally supported animal microRNA targets

Cytoscape: a software environment for integrated models

Clinical implications of dysregulated cytokine production

Limma: linear models for microarray data

STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets

Network-based identification genetic effect of SARS-CoV-2 infections to Idiopathic pulmonary fibrosis (IPF) patients

GOplot: an R package for visually combining expression data with functional analysis

Reprogramming of regulatory network using expression uncovers sex-specific gene regulation in Drosophila

TAGLN mediated stiffness-regulated ovarian cancer progression via RhoA/ROCK pathway

ACE2 interaction networks in COVID-19: a physiological framework for prediction of outcome in patients with cardiovascular risk factors

Decreased expression of ATF3, orchestrated by β-catenin/TCF3, miR-17-5p and HOXA11-AS, promoted gastric cancer progression via increased β-catenin and CEMIP

ClusterProfiler: an R package for comparing biological themes among gene clusters

FABP5 promotes lymph node metastasis in cervical cancer by reprogramming fatty acid metabolism

Inflammation and antiviral immune response associated with severe progression of COVID-19

NetworkAnalyst 3.0: a visual analytics platform for comprehensive gene expression profiling and meta-analysis

Figure Caption Figure 1. Identification of common DEGs between COVID-19 and sarcoidosis

GSE152418 (B) and GSE42832 (C) are presented as volcano plots; blue dots represent down-regulated genes, and yellow plots represent up-regulated genes

The Venn diagram shows that there are 33 common DEGs between COVID-19 and sarcoidosis. (F) Protein-protein interaction network was constructed using common DEGs between COVID-19 and sarcoidosis. (G) Heatmap shows the expression landscape of common DEGs in sarcoidosis dataset

Figure 2. Functional insights into DEGs. We performed GO and KEGG analysis to uncover the molecular function of identified DEGs, including COVID-19-specific DEGs (A), sarcoidosis-specific DEGs (B) and the common DEGs between sarcoidosis and COVID-19 (C)

Kyoto encyclopedia of genes and genomes